IHH Healthcare aims to hike its stake in Fortis to 50%: CEO Prem Kumar Nair

IHH Healthcare sees India as a major growth market. The company plans to increase its stake in Fortis Healthcare. IHH aims to expand its hospital bed count to 10,000 by 2030. Investments will focus on existing Fortis locations and integrating Gleneagles facilities. The group is also repositioning its diagnostics arm.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/8tTCAmY
via IFTTT

Read More

Biocon rolls out two biosimilars in US market

Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They are now available through specialty pharmacies and healthcare providers. The US Food and Drug Administration previously approved them. This launch expands Biocon's portfolio and aims to provide affordable treatment options for patients.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CptEBOD
via IFTTT

Read More

Corporate India brings health intelligence to the fore as preventive care surges: Report

A wave of change is sweeping through Indian businesses as they embrace the significance of employee health. The rise in annual medical screenings and a boost in doctor consultations signify this shift. Young adults, particularly those from Gen Z and the millennial cohort, are at the forefront of this health revolution, demanding mental wellness support as a vital employee benefit.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/G3xhKLU
via IFTTT

Read More

AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/j8et63G
via IFTTT

Read More

Capital with purpose: How capital markets are shaping the future of medicine with Dheeraj Chinthalapelly

Dheeraj Chinthalapelly, with a decade and a half of experience in global capital markets, shares his journey navigating the biotech investment banking, highlighting his focus on capital raising and mergers and acquisitions. He emphasises the importance of advising companies that bring scientific innovation to patients, navigating the evolving biotech capital markets, and prioritising long-term value creation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FeMcGX5
via IFTTT

Read More

Gut response! After protein, it’s fibre’s moment on the shelf

Social media is buzzing with 'maxxing' diet trends, focusing on extreme protein and fiber intake for better health. While these nutrients are important, experts warn that more is not always best. Companies are capitalizing on this, but a balanced approach is key. Consult a doctor for personalized advice. Real food remains the best source for optimal well-being.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lxGvDZi
via IFTTT

Read More

Grey Market: India is ageing faster than its care systems can keep up. A new wave of startups is trying to bridge that gap

A growing number of cases of memory loss and dementia are highlighting India’s lack of early intervention and eldercare support, as the country faces a rapid rise in its ageing population. India has nearly 100 million people above 60, a number expected to exceed 300 million by 2050.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nw4mtSz
via IFTTT

Read More